Objective: Liver cirrhosis is characterized by reduced circulating IGF-I and this has been linked to an adverse clinical outcome. Therefore, we investigated the dynamic changes in circulating total, free, and bioactive IGF-I, IGF-binding protein (IGFBP)-1, IGFBP-2, and IGFBP-1-bound IGF-I (binary complex) during an oral glucose tolerance test (OGTT) in patients with liver cirrhosis. Methods: Seven Caucasian males with liver cirrhosis and seven healthy males matched for age (54.4G 3.2 vs 54.6G4.4 years) and body mass index (25.3G1.2 vs 25.9G1.3 kg/m 2) were studied. Bloo
Background and aims: Cirrhosis is a frequent disease inducing high morbidity and mortality. Availabl...
Background: Approximately 30% of patients who suffer cirrhosis maybe diabetic, called hepatogenous d...
Context: Hepatokines have emerged as potential mediators of obesity-associated comorbidities, such a...
Liver cirrhosis is characterized by reduced circulating IGF-I and this has been linked to an adverse...
Introduction: Serum Insulin-like Growth Factor-1 level decreases in cirrhosis due to reduced growth ...
Background/aims: Impaired growth hormone-insulin like growth factor system in hepatic cirrhosis lead...
Background/Aims: Insulin-like growth factor I (IGF-I) is an anabolic hormone synthesized in the live...
Background/Aims: Insulin-like growth factor I (IGF-I) is an anabolic hormone synthesized in the live...
Background: as liver is the principal organ for metabolism of the carbohydrates, chronic liver disea...
Introduction: Non-alcoholic fatty liver disease (NAFLD) has been described in adult GH deficiency s...
Background: Clinical diabetes occurs in up to 30% of patients with cirrhosis. Diabetes is a negative...
BACKGROUND: The development of hepatocellular carcinoma in liver cirrhosis is associated with altere...
BACKGROUND: The development of hepatocellular carcinoma in liver cirrhosis is associated with altere...
Background Insulin-like growth factor binding protein-1 (IGFBP-1) is a hepatically synthesised prote...
<p><strong>Purpose.</strong> The study was designed to assess the relationship between the level of ...
Background and aims: Cirrhosis is a frequent disease inducing high morbidity and mortality. Availabl...
Background: Approximately 30% of patients who suffer cirrhosis maybe diabetic, called hepatogenous d...
Context: Hepatokines have emerged as potential mediators of obesity-associated comorbidities, such a...
Liver cirrhosis is characterized by reduced circulating IGF-I and this has been linked to an adverse...
Introduction: Serum Insulin-like Growth Factor-1 level decreases in cirrhosis due to reduced growth ...
Background/aims: Impaired growth hormone-insulin like growth factor system in hepatic cirrhosis lead...
Background/Aims: Insulin-like growth factor I (IGF-I) is an anabolic hormone synthesized in the live...
Background/Aims: Insulin-like growth factor I (IGF-I) is an anabolic hormone synthesized in the live...
Background: as liver is the principal organ for metabolism of the carbohydrates, chronic liver disea...
Introduction: Non-alcoholic fatty liver disease (NAFLD) has been described in adult GH deficiency s...
Background: Clinical diabetes occurs in up to 30% of patients with cirrhosis. Diabetes is a negative...
BACKGROUND: The development of hepatocellular carcinoma in liver cirrhosis is associated with altere...
BACKGROUND: The development of hepatocellular carcinoma in liver cirrhosis is associated with altere...
Background Insulin-like growth factor binding protein-1 (IGFBP-1) is a hepatically synthesised prote...
<p><strong>Purpose.</strong> The study was designed to assess the relationship between the level of ...
Background and aims: Cirrhosis is a frequent disease inducing high morbidity and mortality. Availabl...
Background: Approximately 30% of patients who suffer cirrhosis maybe diabetic, called hepatogenous d...
Context: Hepatokines have emerged as potential mediators of obesity-associated comorbidities, such a...
Add to ORKG